Increased degranulation of natural killer cells during acute HCV correlates with the magnitude of virus-specific T cell responses

Hoofnagle, 2002, Course and outcome of hepatitis C, Hepatology, 36, S21 Dustin, 2007, Flying under the radar: the immunobiology of hepatitis C, Annu Rev Immunol, 25, 71, 10.1146/annurev.immunol.25.022106.141602 Shoukry, 2004, Cell-mediated immunity and the outcome of hepatitis C virus infection, Annu Rev Microbiol, 58, 391, 10.1146/annurev.micro.58.030603.123836 Cooper, 2001, The biology of human natural killer-cell subsets, Trends Immunol, 22, 633, 10.1016/S1471-4906(01)02060-9 Degli-Esposti, 2005, Close encounters of different kinds: dendritic cells and NK cells take centre stage, Nat Rev Immunol, 5, 112, 10.1038/nri1549 Moretta, 2006, Effector and regulatory events during natural killer–dendritic cell interactions, Immunol Rev, 214, 219, 10.1111/j.1600-065X.2006.00450.x Ferlazzo, 2002, Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells, J Exp Med, 195, 343, 10.1084/jem.20011149 Vitale, 2005, NK-dependent DC maturation is mediated by TNFα and IFNγ released upon engagement of the NKp30 triggering receptor, Blood, 106, 566, 10.1182/blood-2004-10-4035 Piccioli, 2002, Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells, J Exp Med, 195, 335, 10.1084/jem.20010934 Crotta, 2002, Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein, J Exp Med, 195, 35, 10.1084/jem.20011124 Tseng, 2002, Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions, J Exp Med, 195, 43, 10.1084/jem.20011145 Yoon, 2009, Natural killer cell function is intact after direct exposure to infectious hepatitis C virions, Hepatology, 49, 12, 10.1002/hep.22624 Khakoo, 2004, HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection, Science, 305, 872, 10.1126/science.1097670 Romero, 2008, Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in hepatitis C virus infection outcome, Mol Immunol, 45, 2429, 10.1016/j.molimm.2008.01.002 Golden-Mason, 2008, Altered natural killer cell subset distributions in resolved and persistent hepatitis C virus infection following single source exposure, Gut, 57, 1121, 10.1136/gut.2007.130963 Borsellino, 2007, Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression, Blood, 110, 1225, 10.1182/blood-2006-12-064527 Morishima, 2006, Decreased NK cell frequency in chronic hepatitis C does not affect ex vivo cytolytic killing, Hepatology, 43, 573, 10.1002/hep.21073 Nattermann, 2006, Surface expression and cytolytic function of natural killer cell receptors is altered in chronic hepatitis C, Gut, 55, 869, 10.1136/gut.2005.076463 Meier, 2005, Shared alterations in NK cell frequency, phenotype, and function in chronic human immunodeficiency virus and hepatitis C virus infections, J Virol, 79, 12365, 10.1128/JVI.79.19.12365-12374.2005 Corado, 1997, Impairment of natural killer (NK) cytotoxic activity in hepatitis C virus (HCV) infection, Clin Exp Immunol, 109, 451, 10.1046/j.1365-2249.1997.4581355.x Cox, 2009, Rare birds in North America: acute hepatitis C cohorts, Gastroenterology, 136, 26, 10.1053/j.gastro.2008.11.049 Sherman, 2007, Management of chronic hepatitis C: consensus guidelines, Can J Gastroenterol, 21, 25C, 10.1155/2007/138245 Badr, 2008, Early interferon therapy for hepatitis C virus infection rescues polyfunctional, long-lived CD8+ memory T cells, J Virol, 82, 10017, 10.1128/JVI.01083-08 Alter, 2004, Increased natural killer cell activity in viremic HIV-1 infection, J Immunol, 173, 5305, 10.4049/jimmunol.173.8.5305 Vallejo, 2004, Opioid therapy and immunosuppression: a review, Am J Ther, 11, 354, 10.1097/01.mjt.0000132250.95650.85 Novick, 1989, Natural killer cell activity and lymphocyte subsets in parenteral heroin abusers and long-term methadone maintenance patients, J Pharmacol Exp Ther, 250, 606 Diepolder, 1997, Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection, J Virol, 71, 6011, 10.1128/jvi.71.8.6011-6019.1997 Lauer, 2004, High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection, Gastroenterology, 127, 924, 10.1053/j.gastro.2004.06.015 Lauer, 2005, Full-breadth analysis of CD8+ T-cell responses in acute hepatitis C virus infection and early therapy, J Virol, 79, 12979, 10.1128/JVI.79.20.12979-12988.2005 Smyk-Pearson, 2006, Differential antigenic hierarchy associated with spontaneous recovery from hepatitis C virus infection: implications for vaccine design, J Infect Dis, 194, 454, 10.1086/505714 Robertson, 1990, Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis, J Immunol, 145, 3194, 10.4049/jimmunol.145.10.3194 Caligiuri, 2008, Human natural killer cells, Blood, 112, 461, 10.1182/blood-2007-09-077438 Romagnani, 2007, CD56brightCD16− killer Ig-like receptor-NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation, J Immunol, 178, 4947, 10.4049/jimmunol.178.8.4947 Deignan, 2002, Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection, J Hepatol, 37, 101, 10.1016/S0168-8278(02)00072-7 Boisvert, 2003, Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes, J Hepatol, 38, 67, 10.1016/S0168-8278(02)00328-8 Kawarabayashi, 2000, Decrease of CD56(+)T cells and natural killer cells in cirrhotic livers with hepatitis C may be involved in their susceptibility to hepatocellular carcinoma, Hepatology, 32, 962, 10.1053/jhep.2000.19362 Oliviero, 2009, Natural killer cell functional dichotomy in chronic hepatitis B and chronic hepatitis C virus infections, Gastroenterology, 137, 1151, 10.1053/j.gastro.2009.05.047 Ahlenstiel, 2010, Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-α-dependent manner, Gastroenterology, 138, 325, 10.1053/j.gastro.2009.08.066 Friedman, 2003, Microbial infections, immunomodulation, and drugs of abuse, Clin Microbiol Rev, 16, 209, 10.1128/CMR.16.2.209-219.2003 Ugen, 2006, Injecting drugs of abuse and immunity: implications for HIV vaccine testing and efficacy, Springer Semin Immunopathol, 28, 281, 10.1007/s00281-006-0045-0 Wang, 2008, Opiate abuse, innate immunity, and bacterial infectious diseases, Arch Immunol Ther Exp (Warsz), 56, 299, 10.1007/s00005-008-0035-0 De Maria, 2007, Increased natural cytotoxicity receptor expression and relevant IL-10 production in NK cells from chronically infected viremic HCV patients, Eur J Immunol, 37, 445, 10.1002/eji.200635989 Bonorino, 2009, Fine characterization of intrahepatic NK cells expressing natural killer receptors in chronic hepatitis B and C, J Hepatol, 51, 458, 10.1016/j.jhep.2009.05.030 Jinushi, 2004, Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cell-induced modulation of dendritic cell functions in chronic hepatitis C virus infection, J Immunol, 173, 6072, 10.4049/jimmunol.173.10.6072 Alter, 2004, CD107a as a functional marker for the identification of natural killer cell activity, J Immunol Methods, 294, 15, 10.1016/j.jim.2004.08.008 Krebs, 2009, NK-cell-mediated killing of target cells triggers robust antigen-specific T-cell-mediated and humoral responses, Blood, 113, 6593, 10.1182/blood-2009-01-201467 Andoniou, 2005, Interaction between conventional dendritic cells and natural killer cells is integral to the activation of effective antiviral immunity, Nat Immunol, 6, 1011, 10.1038/ni1244 Crispe, 2006, Cellular and molecular mechanisms of liver tolerance, Immunol Rev, 213, 101, 10.1111/j.1600-065X.2006.00435.x Crispe, 2009, The liver as a lymphoid organ, Annu Rev Immunol, 27, 147, 10.1146/annurev.immunol.021908.132629